Research Topics
Genomes and GenesSpecies | Lisa F LinczSummaryAffiliation: University of Newcastle Country: Australia Publications
|
Detail Information
Publications
Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V LeidenLisa F Lincz
Hunter Haematology Research Group, Calvary Mater Newcastle Hospital, NSW, Australia
Thromb Res 129:192-6. 2012..Here we sought to determine if these subjects differed in their plasma levels of FVL and if this was related to MP concentrations and/or history of thrombosis...- Thrombin generation as a predictor of radiotherapy induced skin erythemaLisa F Lincz
Department of Haematology, Calvary Mater Newcastle, NSW, Australia
Radiother Oncol 90:136-40. 2009..Based on the recent findings in patients suffering from chronic urticaria, we sought to determine if similar mechanisms of hypercoagulation contributed to comparable skin reactions during radiotherapy... 
Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variantLisa F Lincz
Department of Haematology, Calvary Mater Newcastle, Newcastle, NSW, Australia
Neoplasia 10:1131-7. 2008..This study shows that telomerase activity in melanoma cells is best determined by the absolute expression of full-length hTERT mRNA and indicates a role for the hTERT beta deletion variant in the negative regulation of enzyme activity...
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenLisa F Lincz
Hunter Haematology Research Group, Newcastle Misericordiae Hospital, Waratah, Australia
Blood Coagul Fibrinolysis 18:559-64. 2007....- Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V LeidenLisa F Lincz
Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, Australia
Pathophysiol Haemost Thromb 35:435-9. 2006..The recent introduction of diagnostic ETP measurements in the form of the calibrated automated thrombin generation from Thrombinoscope and the TechnoThrombin from Baxter should facilitate such studies... - Circulating microparticles are elevated in carriers of factor V LeidenAnoop K Enjeti
Hunter Haematology Research Group, Calvary Mater Newcastle, Edith Street, Waratah, NSW 2298, Australia
Thromb Res 126:250-3. 2010..This study was carried out to evaluate if increased numbers or procoagulant potential of circulating MP contribute to the heterogeneity in occurrence of thrombosis in heterozygotes carrying Factor V Leiden (FVL) mutation... - Genetic variations in benzene metabolism and susceptibility to multiple myelomaLisa F Lincz
Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Edith Street, Waratah, NSW 2298, Australia
Leuk Res 31:759-63. 2007..65, 2.49 and 13 times more likely to have MM (P(trend)=0.001)... - Oncolytic Coxsackievirus A21 as a novel therapy for multiple myelomaGough G Au
The Picornaviral Research Unit, School of Biomedical Sciences, Faculty of Health, The University of Newcastle, Newcastle, NSW, Australia
Br J Haematol 137:133-41. 2007..Data generated in this study suggests that CVA21 virotherapy may have potential applications as a systemic anti-tumour agent for MM, or in the ex vivo purging of malignant plasma cells prior to autologous stem cell transplantation... - Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myelomaLisa F Lincz
Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, NSW, Australia
Br J Haematol 120:1051-4. 2003..4-fold lower risk of follicular (odds ratio = 0.41, 95% confidence interval: 0.19-0.88, p = 0.02) but not diffuse large B-cell lymphoma. MM patients showed no significant difference in the polymorphisms compared with control subjects... - Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R alleleLisa F Lincz
Hunter Haematology Research Group, Newcastle Mater Misericordiae Hospital, Waratah, NSW 2298, Australia
Int J Cancer 120:1930-4. 2007..This would severely decrease TS expression and may have implications for predicting efficacy and toxicity of therapy with commonly used fluorouracil-based therapy regimes... - Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenomGeoffrey K Isbister
Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
Toxicon 56:75-85. 2010..ETP is a useful assay to investigate mechanisms of other procoagulant venoms and is a robust method of assessing antivenom efficacy... - Microparticles in health and diseaseAnoop K Enjeti
Department of Haematology level 4, Hunter Haematology Research Group, New Medical Building, Calvary Mater Hospital, Waratah Newcastle, Australia
Semin Thromb Hemost 34:683-91. 2008.... - Detection and measurement of microparticles: an evolving research tool for vascular biologyAnoop K Enjeti
Department of Haematology, Calvary Mater Hospital, Waratah Newcastle, Australia
Semin Thromb Hemost 33:771-9. 2007..Although it has evolved as an important vascular biology research tool, microparticle detection needs further evaluation and refinement before it becomes truly useful as a clinical tool... - Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole bloodJennette A Sakoff
Department of Medical Oncology, Newcastle Mater Misericordiae Hospital, Newcastle, Locked Bag No 7, Hunter Region Mail Center, 2310, NSW, Australia
Leuk Lymphoma 43:2017-20. 2002..83, P < 0.001). Thus, telomere length in haemopoietic stem cells can be determined from that of whole or fractionated PB in future studies of haematological disorders... - Xenobiotic gene polymorphisms and susceptibility to multiple myelomaLisa F Lincz
Haematologica 89:628-9. 2004....